These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2807964)

  • 1. [The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].
    Knönagel H; Hauri D
    Helv Chir Acta; 1989 Aug; 56(3):347-50. PubMed ID: 2807964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
    Ahmann FR; Crawford ED; Kreis W; Levasseur Y
    Cancer Res; 1987 Sep; 47(17):4736-9. PubMed ID: 3621171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E; Veldhuis JD; Wells SA; Santen RJ
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aminoglutethimide in the treatment of advanced prostatic cancer].
    Bauer HW; Schmeller NT; Schmiedt E
    Urologe A; 1985 Jan; 24(1):46-8. PubMed ID: 4039084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.
    Smith MR; Kaufman D; George D; Oh WK; Kazanis M; Manola J; Kantoff PW
    Cancer; 2002 Nov; 95(9):1864-8. PubMed ID: 12404279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
    Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M
    Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aminoglutethimide and cancer of the prostate].
    Bonneterre J
    Bull Cancer; 1986; 73(1):56-60. PubMed ID: 3779123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
    Harris AL
    Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
    Dawson N; Figg WD; Brawley OW; Bergan R; Cooper MR; Senderowicz A; Headlee D; Steinberg SM; Sutherland M; Patronas N; Sausville E; Linehan WM; Reed E; Sartor O
    Clin Cancer Res; 1998 Jan; 4(1):37-44. PubMed ID: 9516950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal androgen blockade in relapsed prostate cancer.
    Geller J; Albert JD
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1127-31. PubMed ID: 2934257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer.
    Plowman PN; Perry LA; Chard T
    Br J Urol; 1987 Mar; 59(3):255-7. PubMed ID: 3567487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
    Debruyne FM
    Am J Clin Oncol; 1988; 11 Suppl 1():S33-5. PubMed ID: 2968760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroidism associated with aminoglutethimide in patients with prostate cancer.
    Figg WD; Thibault A; Sartor AO; Mays D; Headlee D; Calis KA; Cooper MR
    Arch Intern Med; 1994 May; 154(9):1023-5. PubMed ID: 8179445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
    Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
    J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
    Borgmann V; al-Abadi H; Nagel R
    Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of buserelin in advanced prostate cancer and comparison with historical controls.
    Soloway MS
    Am J Clin Oncol; 1988; 11 Suppl 1():S29-32. PubMed ID: 3133944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.